PBAC Public Summary Documents - November 2020 meeting

5 March 2021 - The Public Summary Documents (positive recommendations and subsequent decisions not to recommend) from the November 2020 PBAC ...

Read more →

AstraZeneca CEO Pascal Soriot says ­vaccine is 100 per cent effective

5 March 2021 - The global head of AstraZeneca has declared the company’s ­vaccine is 100 per cent effective against ...

Read more →

Ofev (nintedanib) receives positive recommendation from CADTH and INESSS for the treatment of progressive fibrosing interstitial lung diseases

4 March 2021 - Ofev is the first treatment available in Canada for chronic fibrosing interstitial lung diseases with a progressive ...

Read more →

Italy, EU refuse AstraZeneca request to ship 250,000 doses of vaccine to Australia

5 March 2021 - Italy and the European Union have blocked a shipment of the Oxford-AstraZeneca coronavirus vaccine destined for Australia ...

Read more →

PHARMAC swapping epilepsy drugs 'cannot be discounted' as a cause of deaths — neurologist

4 March 2021 - An Auckland paediatric neurologist says PHARMAC's decision to switch to a generic version of an epilepsy drug ...

Read more →

The PHARMAC non-review?

4 March 2021 - The recently announced PHARMAC review is fatally flawed.  ...

Read more →

NICE rejects rare blood cancer treatment Poteligeo in final appraisal

4 March 2021 - The UK’s NICE has not recommended Kyowa Kirin’s Poteligeo for the treatment of adults living with ...

Read more →

Cancer patient told palliative care only option after being rejected PHARMAC funding

2 March 2021 - The drug-buying agency was placed under an independent review today after the Prime Minister said she ...

Read more →

PHARMAC ripe for reassessment

3 March 2021 - New Zealand’s drug buying agency PHARMAC has long been, simultaneously, a good thing in itself and ...

Read more →

CSL warns AstraZeneca booster shots not available until end of year

2 March 2021 - Australia’s COVID-19 vaccine maker CSL says it is open to making booster shots for AstraZeneca for ...

Read more →

NICE backs NHS use of Lilly’s Olumiant in eczema

3 March 2021 - Eli Lilly’s Olumiant has received a UK NICE recommendation for the treatment of moderate-to-severe atopic dermatitis ...

Read more →

NHS prescription charges set to rise in England

2 March 2021 - The NHS prescription charge in England is set to increase to £9.35 from 1 April 2021 ...

Read more →

Government announces review into PHARMAC

2 March 2021 - The Government is following through on an election promise to conduct an independent review into PHARMAC, ...

Read more →

Medicines New Zealand supportive of Government’s PHARMAC review assuming it is not a box-ticking exercise

2 March 2021 - Medicines New Zealand is supportive of the proposed review into PHARMAC if it is intended to improve ...

Read more →

Review asks how Government can get the new drugs it wants funded

2 March 2021 - The much-vaunted PHARMAC inquiry, being announced today, will investigate how the drug-buying agency can be brought ...

Read more →